Filter

31 - 40 of 93 Results

  • Trans People in the U.S.: Identities, Demographics, and Wellbeing

    Issue Brief

    The recently released KFF/Washington Post Trans Survey is the most in-depth, representative survey of transgender adults living in the U.S. Building on that report, and using the survey data, this analysis provides the most comprehensive representative profile of trans Americans ever complied, while also offering insights on their experiences in the health care system.

  • LGBT+ People’s Health Status and Access to Care

    Issue Brief

    This report, based on a nationally representative 2022 KFF survey, provides an analysis of the health experiences of self-identified LGBT+ adults in the U.S. compared to their non-LGBT+ counterparts.

  • What Do We Know About People with HIV Who Are Not Engaged In Regular HIV Care?

    Issue Brief

    This analysis uses nationally representative data to assess the characteristics and experiences of people with HIV who are out of regular HIV care. Reaching and engaging people with HIV who are not in care involves addressing the complex and systemic barriers they face, which impede both their health and wellbeing and also the HIV response in the U.S. more broadly.

  • Mpox One Year Later: Where is the U.S. today?

    Issue Brief

    This brief provides an overview of the impact of mpox in the U.S. one year after a case of was identified domestically and the federal response to date, and discusses the future outlook.

  • Medicaid and People with HIV

    Issue Brief

    This data note provides an overview of the role of the Medicaid program for people with and at risk for HIV.

  • Assessing Monkeypox (MPX) Vaccine Eligibility Across the United States

    Issue Brief

    This analysis examines jurisdictional approaches to eligibility for monkeypox (MPX) vaccine. Overall, almost all jurisdictions have, at minimum, adopted the current approach laid out by the CDC. However, there is substantial variation in how eligibility is defined. Additionally, several jurisdictions lack clear criteria or information on who is eligible or where to get vaccinated. This may impact on who gets vaccinated, lead to geographic disparities, and raises potentially equity challenges.

  • Monkeypox Vaccine Roll-out in the U.S. – Are Jurisdictions Requesting All Their Doses?

    Policy Watch

    This analysis examines monkeypox vaccine allocations and jurisdictional requests. It explores jurisdictional request rate (the number of vaccine does requested as a share of the jurisdiction’s allocation from HHS) for JYNNEOS, the preferred vaccine. Overall, while most jurisdictions have requested at least their full supply, some are well below that mark, raising questions about how quickly their at-risk populations can get protected.